Bacteriophage Therapy: Current Strategies and Future Perspectives
MedComm · 2026-03 · 7 (3)
DOI: 10.1002/mco2.70645 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 01.03.2026. Verfasst von Zihe Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine Peking University Third Hospital Beijing China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 311 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Beijing Municipality, Peking University Third Hospital.
Abstract (Originalsprache)
Antimicrobial resistance represents a significant global health threat, demanding alternative treatments beyond traditional antibiotics. Phage therapy has resurged as a promising solution to address this challenge. This manuscript offers an in‐depth examination of phage applications in clinical settings, encompassing the treatment of multidrug‐resistant infections, prevention of hospital‐acquired infections, and development of phage‐based vaccines. Advanced strategies are explored, including phage–antibiotic synergy, biomaterial‐enhanced delivery systems to improve phage stability, and the rational design of engineered phages to expand host range and optimize lytic efficacy. Additionally, the application of genetic engineering to broaden phage host ranges and convert temperate phages into lytic variants is discussed. In hospital infection prevention, phages demonstrate substantial potential, such as eliminating bacterial biofilms on medical devices, disinfecting environmental surfaces, and controlling waterborne pathogens in hospital water systems. Furthermore, phages offer a versatile platform for vaccine development, facilitating efficient antigen display and nucleic acid delivery. Despite progress, challenges persist in pharmacokinetics, standardized production, and regulatory approval. This review synthesizes recent preclinical and clinical developments, emphasizing the transformative potential of phage‐based therapies while acknowledging the barriers to their clinical implementation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine Peking University Third Hospital Beijing China.
- Department of Pulmonary and Critical Care Medicine Peking University Third Hospital Beijing China.
- State Key Laboratory of Green Biomanufacturing College of Life Science and Technology Beijing University of Chemical Technology Beijing China.
- School of Life Sciences Tianjin University Tianjin China.
ORCID-Profile: Huahao Fan
Förderung
- Natural Science Foundation of Beijing Municipality
- Peking University Third Hospital
Zitieren
APA
Zhou, Z., Fu, H., Li, M., Han, Z., Wu, Z., Fan, H., Shen, N., & Zheng, J. (2026). Bacteriophage Therapy: Current Strategies and Future Perspectives. MedComm, 7(3). https://doi.org/10.1002/mco2.70645
Vancouver
Zhou Z, Fu H, Li M, Han Z, Wu Z, Fan H, et al. Bacteriophage Therapy: Current Strategies and Future Perspectives. MedComm. 2026;7(3). doi:10.1002/mco2.70645
BibTeX
@article{Zhou2026,
author = {Zhou, Zihe and Fu, Hanyu and Li, Mengzhe and Han, Zhongyu and Wu, Zhenchao and Fan, Huahao and Shen, Ning and Zheng, Jiajia},
title = {Bacteriophage Therapy: Current Strategies and Future Perspectives},
journal = {MedComm},
year = {2026},
volume = {7},
number = {3},
doi = {10.1002/mco2.70645}
}
EUVIMED